1 – 15 of 15
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients—a SCHEDULE trial substudy
(
- Contribution to journal › Article
-
Mark
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients : Long-term Follow-up From the Randomized SCHEDULE Study
(
- Contribution to journal › Article
-
Mark
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients : Design of the randomized controlled EVOLVD trial
(
- Contribution to journal › Article
- 2018
-
Mark
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
(
- Contribution to journal › Article
-
Mark
Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry
(
- Contribution to journal › Article
- 2017
-
Mark
Effect of Calcineurin Inhibitor-Free Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate after Heart Transplantation
(
- Contribution to journal › Article
-
Mark
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up : Results of a randomized controlled trial (SCHEDULE)
(
- Contribution to journal › Article
- 2016
-
Mark
Wound complications and surgical events in de novo heart transplant patients treated with everolimus: Post-hoc analysis of the SCHEDULE trial.
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
(
- Contribution to journal › Article
- 2013
-
Mark
Three decades of heart transplantation in Scandinavia: long-term follow-up
(
- Contribution to journal › Article
- 2012
-
Mark
Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies
(
- Contribution to journal › Article
-
Mark
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: The significance of baseline glomerular filtration rate
(
- Contribution to journal › Article
- 2010
-
Mark
Two-Year Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial.
(
- Contribution to journal › Article
-
Mark
Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial.
(
- Contribution to journal › Article
- 2009
-
Mark
Cyclosporine C2 Levels Have Impact on Incidence of Rejection in De Novo Lung but Not Heart Transplant Recipients: The NOCTURNE Study
2009) 29th Annual Meeting and Scientific Session of the International-Society-for-Heart-and-Lung-Transplantation 28(9). p.919-926(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding